Infection Control Market Size to Hit USD 49.7 Billion by 2033 | With a 6.22% CAGR

Market Overview:

The infection control market is experiencing rapid growth, driven by sharp rise in healthcare-associated infections (hais) and patient safety mandates, government initiatives and major public health investments, and rapid healthcare infrastructure expansion and innovation. According to IMARC Group’s latest research publication, “Infection Control Market Report by Type (Equipment, Services, Consumables), End User (Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2025–2033”, the global infection control market size reached USD 28.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025–2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Get Your Free "Infection Control Market" Sample PDF Report Now!

Our report includes:

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Infection Control Market

• Sharp Rise in Healthcare-Associated Infections (HAIs) and Patient Safety Mandates

The relentless increase in healthcare-associated infections has put infection control front and center across clinics, hospitals, and even long-term care. Globally, up to 10% of patients in developing regions contract an HAI during their hospital stay, with the World Health Organization noting that HAIs cause substantial economic and patient burdens. These preventable incidents affect millions every year, spurring mandatory infection prevention actions by regulators. Governments and accreditation bodies are rolling out stricter hygiene protocols and monitoring, pushing demand for advanced disinfection, sterilization, and personal protective equipment. With regulators prioritizing patient safety and hospitals seeking to avoid costly infection outbreaks, robust infection control has become a non-negotiable worldwide.

• Government Initiatives and Major Public Health Investments

National health authorities and organizations like the WHO have rolled out high-profile infection prevention initiatives, backed by large-scale funding and tight compliance requirements. In India, programs such as Kayakalp and Swacchhta boost hospital hygiene—while globally, regulations like the Biomedical Waste Management Rules and National Patient Safety Framework guide hospital operations. Many countries have introduced regular hygiene audits, mandatory reporting, and information, education, and communication campaigns for healthcare professionals. These efforts drive significant adoption of cleaning, disinfection, and sterilization products in public and private institutions. In turn, government spending on infection prevention infrastructure and training has catalyzed a steady rise in infection control market size, surpassing $50billion in annual value.

• Rapid Healthcare Infrastructure Expansion and Innovation

Another major growth accelerator is the boom in healthcare infrastructure—more clinics, hospitals, and outpatient centers are opening worldwide as healthcare spending climbs. Facilities are upgrading to meet higher hygiene standards, particularly in high-growth markets such as Asia Pacific and North America, which together account for a large share of infection control spending. Alongside this, leading companies like 3M, Ecolab, and Steris have invested heavily in cutting-edge solutions, from UV-C disinfection robots to antimicrobial surface coatings and advanced air filtration, which can cut HAIs by up to 30%. This wave of innovation, coupled with increasing numbers of surgical and diagnostic procedures, continues to expand the market’s horizon

Key Trends in the Infection Control Market

• High-Tech Infection Control: Automation and Smart Solutions

The rise of technology is transforming infection control into a precision field. Hospitals now deploy automated disinfection robots, UV-C light systems, and smart sensor-driven hand hygiene stations for constant real-time monitoring of compliance and efficacy. For example, UV-C systems and hydrogen peroxide vapor units are showing strong results in reducing microbial contamination in operating rooms and patient wards. Leading infection control platforms also integrate AI-powered dashboards, helping healthcare managers prevent lapses swiftly. As new regulations demand traceability and auditability, digital tools that track hygiene, schedule procedures, and verify sterilization proof are increasingly the industry standard.

• Sustainability and Environmental Stewardship

Environmental responsibility is now a key consideration for infection control suppliers and healthcare systems. There’s mounting demand for low-toxicity cleaning agents, closed-loop chemical systems, and biodegradable wipes that minimize harm to staff, patients, and the planet. Hospitals and care providers are asking vendors not just about cleaning efficacy, but also about their environmental credentials and commitments. In the public sector, sustainable procurement for infection control is becoming the norm. Leaders like Spectrum Blue are pioneering photocatalytic surface coatings and greener disinfection methods, driving the market toward products that balance infection safety with reduced ecological footprints.

• Growing Focus on Education, Standards, and Partnership

Infection control now goes beyond products and technology—with a clear shift to comprehensive training, continuous education, and collaborative partnerships. Regular workshops, updated guidelines, and ongoing skills assessments are now built into hospital policies. Networks like the APIC Research Network connect practitioners for sharing best practices and research data, while major public health bodies regularly release updated protocols for HAIs and device-related infection prevention. Facilities increasingly demand strong credentials, quick adaptation to new standards, and evidence of measurable outcomes from their partners. This focus on education and collaboration ensures infection prevention is a shared responsibility across entire healthcare ecosystems.

Unlock Exclusive Insights—Buy the Full Report with a Discount!

Leading Companies Operating in the Global Infection Control Industry:

• 3M Company
• Advanced Sterlization Products Services Inc. (Fortive Corporation)
• Belimed AG (Metall Zug)
• Cantel Medical Corp.
• Getinge AB
• Matachana
• Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
• MMM Münchener Medizin Mechanik GmbH
• Pal International
• Sterigenics U.S. LLC (Sotera Health Holdings LLC)
• Steris Corporation
• TSO3 Inc. (Stryker Corporation)

Infection Control Market Report Segmentation:

By Type:

Equipment

• Disinfectors
• Washers
• Flushers
• Ultrasonic Cleaners
• Sterilization Equipment
• Heat Sterilization
• Low Temperature Sterilization
• Radiation Sterilization
• Filtration-Based Sterilization
• Others

Services

• Contract Sterilization
• ETO Sterilization
• Gamma Sterilization
• E-Beam Sterilization
• Steam Sterilization
• Infectious Waste Disposal

Consumables

• Disinfectants
• Sterilization Consumables
• Personal Protective Equipment
• Others

Consumables hold the biggest market share as they are designed for ease of use and compatibility with existing healthcare protocols, thereby enhancing compliance with safety and hygiene standards.

By End User:

• Hospitals and Clinics
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others

Hospitals and clinics represent the largest segment owing to the increasing number of patients seeking effective healthcare solutions.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America’s dominance in the infection control market is attributed to the rising emergence of novel pathogens.

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302